期刊文献+

抗菌药物PK/PD理论及其临床应用研究进展 被引量:5

Research Progress in the Theory and Clinical Application of Antibacterial PK/PD
原文传递
导出
摘要 由于抗菌药物的不合理使用,造成细菌耐药率逐年升高。抗菌药物的药物代谢动力学/药物效应动力学(PK/PD)研究可充分考虑病原体、宿主和药物三者的相互关系,反映抗菌药物杀菌效应及不良反应与血药浓度变化之间的关系,对抗菌药物的开发及使用等具有重要价值。从PK/PD模型、相关理论及其在临床应用等方面进行综述,旨在为临床合理使用抗菌药物,减少耐药菌的产生提供参考。 Due to the irrational use of antimicrobial agents,bacterial resistance has been increasing year by year.PK/PD study fully considers the relationship among pathogens,hosts and drugs,which reflects the relationship between bactericidal effects and adverse reactions of antibiotics and the change of blood concentration,which is of much value to the development and application of antibiotics.In this paper,the basic theory of PK/PD,related models and clinical applications are reviewed,with an aim to provide a basis for the rational use of antimicrobial agents and the reduction of drug-resistant bacteria.
作者 沈爱宗 张圣雨 陈泳伍 晨迪 陈飞虎 黄晓晖 邵蓉 SHEN Aizong;ZHANG Shengyu;CHEN Yongwu;CHEN Di;CHEN Feihu;HUANG Xiaohui;SHAO Rong(School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing 211198,China;Department of Pharmacy,the First Affiliated Hospital of University of Science and Technology of China(Anhui Provincial Hospital),Hefei 230001,China;College of Pharmacy,Anhui University of Chinese Medicine,Hefei 230012,China;College of Pharmacy,Anhui Medical University,Hefei 230032,China)
出处 《药学进展》 CAS 2019年第11期880-880,I0003-I0006,共5页 Progress in Pharmaceutical Sciences
关键词 药物代谢动力学/药物效应动力学 抗菌药物 临床应用 PK/PD antimicrobial agent clinical application
  • 相关文献

参考文献8

二级参考文献62

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:244
  • 2<应用抗菌药物防治外科感染的指导意见>撰写协作组.应用抗菌药物防治外科感染的指导意见(草案)ⅩⅦ——骨和关节感染[J].中华外科杂志,2005,43(4):270-272. 被引量:43
  • 3Bonate PL. A brief introduction to Monte Carlo simulation[J].Clinical Pharmacokinetics,2001.15-22.
  • 4Lodise TP,Lomaestro BM,Drusano GL. Application of antimicrobial pharmacodynamic concepts into clinical practice:focus on beta-lactam antibiotics:insights from the Society of Infectious Diseases Pharmacists[J].PHARMACOTHERAPY,2006.1320-1332.
  • 5Mattoes HM,Kuti JL,Drusano GL. Optimizing antimicrobial pharmacodynamics:dosage strategies for meropenem[J].Clinical Therapeutics,2004.1187-1198.
  • 6Bulitta JB,Kinzig M,Jakob V. Nonlinear pharmacokinetics of piperacillin in healthy volunteersimplications for optimal dosage regimens[J].British Journal of Clinical Pharmacology,2010.682-693.
  • 7Higuchi K,Ikawa K,Ikeda K. Peritoneal pharmacokinetics of cefepime in laparotomy patients with inflammatory bowel disease,and dosage considerations for surgical intra-abdominal infections based on pharmacodynamic assessment[J].Journal of Infection and Chemotherapy,2008.110-116.
  • 8Ikawa K,Nakashima A,Morikawa N. Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic target attainment[J].ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,2011.5609-5615.
  • 9Stein GE,Kulhanek G,Smith CL. Pharmacokinetics and monte carlo simulations of doripenem in patients with febrile neutropenia[J].Annals of Pharmacotherapy,2012.1281-1286.
  • 10Akers KS,Cota JM,Frei CR. Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration[J].ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,2011.4639-4642.

共引文献500

同被引文献72

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部